Higher Incidence of Relapse With Peripheral Blood Rather Than Marrow As a Source of Stem Cells in Adults With Acute Myelocytic Leukemia Autografted During the First Remission | Zendy

Norbert Claude Gorin | Zendy; Myriam Labopin | Zendy; Didier Blaise | Zendy; Josy Reiffers | Zendy; Giovanna Meloni | Zendy; Mauricette Michallet | Zendy; Théo de Witte | Zendy; Michel Attal | Zendy; Bernard Rio | Zendy; F Witz | Zendy; L Fouillard | Zendy; Roel Willemze | Zendy; Vanderson Rocha | Zendy

Open Access

Higher Incidence of Relapse With Peripheral Blood Rather Than Marrow As a Source of Stem Cells in Adults With Acute Myelocytic Leukemia Autografted During the First Remission

Author(s) -

Norbert Claude Gorin,

Myriam Labopin,

Didier Blaise,

Josy Reiffers,

Giovanna Meloni,

Mauricette Michallet,

Théo de Witte,

Michel Attal,

Bernard Rio,

F Witz,

L Fouillard,

Roel Willemze,

Vanderson Rocha

Publication year - 2009

Publication title -

journal of clinical oncology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 10.482

H-Index - 548

eISSN - 1527-7755

pISSN - 0732-183X

DOI - 10.1200/jco.2008.20.1400

Subject(s) - medicine , transplantation , hazard ratio , bone marrow , acute leukemia , leukemia , gastroenterology , incidence (geometry) , stem cell , surgery , confidence interval , physics , biology , optics , genetics

The cell source for autologous stem cell transplantation has shifted from bone marrow (BM) to peripheral blood (PB). In acute myelocytic leukemia (AML), for patients who receive transplants during first complete remission (CR1), no prospective randomized study has compared relapse incidence (RI) to cell source.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research